“To date, there is insufficient scientific evidence on the efficacy of ivermectin for the prevention or treatment of Covid-19. Thus, SAHPRA’s position, as communicated on 28 January 2021, remains as stated,” reads the statement.It said it would continue to monitor emerging scientific data and respond accordingly, also clarifying it had not received any application for the registration of an ivermectin-containing medicine for the management of Covid-19.
Last month, AfriForum lodged an urgent court application against SAHPRA and Health Minister Dr Zweli Mkhize in a bid to have Ivermectin approved for human use.The Pretoria high court ruled that medicines containing Ivermectin may be compounded and made accessible in accordance with the provisions of section 14 of the act.